Pay in 4 interest-free payments of $6.38 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Derived from angiotensin IV, Dihexa crosses the blood-brain barrier and promotes synaptogenesis, making it a promising candidate for treating neurodegenerative diseases such as Alzheimers and Parkinsons
Some people prefer wearing disposable gloves for extra protection
Results: Results vary depending on peptide selection, consistency, lifestyle factors, and individual response
Unlike many peptides that are studied primarily for a single biological function, GHK-Cu has been examined across a broad spectrum of cellular processes
This prolongs its half-life by up to 15 hours but reduces the affinity to the insulin-like growth factor 1 receptors
Initially investigated for its potential to treat neurodegenerative diseases like Alzheimers and Parkinsons, this small synthetic peptide is known to bind with high affinity to hepatocyte growth factor (HGF) and its receptor c-Met, thereby promoting neuronal differentiation, dendritic branching, and synaptic plasticity
